Skip to main content
Clinical Trials/DRKS00027459
DRKS00027459
Completed
N/A

Evaluation of the effectiveness of an online-based support program for the treatment of depression (Novego®) - A randomized controlled trial

IVP Networks GmbH0 sites311 target enrollmentDecember 23, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
F32.0
Sponsor
IVP Networks GmbH
Enrollment
311
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 23, 2021
End Date
June 6, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
IVP Networks GmbH

Eligibility Criteria

Inclusion Criteria

  • one of the following diagnoses according to ICD\-10 made by specialists or psychotherapists: F32\.0, F32\.1, F32\.2, F32\.8, F32\.9, F33\.0, F33\.1, F33\.2, F33\.8, F33\.9, F34\.1
  • A sum score on the PHQ\-9 at the time of the baseline interview of at least 5 (at least mild expression of depression)
  • informed consent
  • access to the Internet
  • sufficient knowledge of the German language
  • willingness to participate in three anonymous online surveys and willingness to independently use Novego \- Depressionen bewältigen®.
  • Patients must be in a stable therapy situation (pharmacotherapy and/or psychotherapy or waiting situation) at least 4 weeks before randomization and should maintain this situation as far as possible during the study period.

Exclusion Criteria

  • the presence of a psychotic or bipolar disorder (lifetime)
  • acute suicidal behavior within the last 4 weeks
  • alcohol or substance dependence within the last 6 months
  • current use of antipsychotics
  • Presence of a serious illness which, in the opinion of the investigator, precludes the patient's participation in the study until the end of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials